PROMAZINE
Clinical Indication
Short term adjunctive management of psychomotor agitation
Comments
Non-Formulary
No longer recommended for use in dementia
Date of classification
November 2025
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.